Results 111 to 120 of about 99,236 (370)

The Immunogenetics of Autoimmune Cholestasis

open access: yesClinics in Liver Disease, 2016
The immune-mediated hepatobiliary diseases, primary biliary cirrhosis and primary sclerosing cholangitis are relatively rare, albeit and account for a significant amount of liver transplant activity and liver-related mortality globally. Precise disease mechanisms are yet to be described although a contributory role of genetic predisposition is firmly ...
Palak J. Trivedi, Gideon M. Hirschfield
openaire   +3 more sources

Revealing of H. pylori markers at patients with acute viral hepatitises

open access: yesЖурнал инфектологии, 2014
O-antigenes of H. рylori have been revealed аt patients with acute viral hepatitis (AVH) (57,7%), more often at patients with a cholestasis, than without cholestasis (in feces – 48,6% and 35,4%, in CIC – 14,8% and 4,5%, accord., and VacA (43,5%) and a ...
S. N. Zuevskaja   +4 more
doaj   +1 more source

Etiologies of neonatal cholestasis at a tertiary hospital in Bangladesh

open access: yesPaediatrica Indonesiana, 2020
Background Neonatal cholestasis is an important etiology of chronic liver disease in young children. It has a varied etiology. There is considerable delay in presentation and diagnosis of neonatal cholestasis in Bangladesh.
Md. Benzamin   +8 more
doaj   +1 more source

Gluten‐free diet during pregnancy and pregnancy outcome: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective A gluten‐free diet (GFD) is becoming increasingly popular, especially among young females, and including those without diagnosed celiac disease (CD). Whether a GFD is appropriate during pregnancy remains unclear. Our primary aim was to evaluate the association of a GFD and neonatal birthweight and incidence of large for gestational ...
Johanna Kristiina Reijonen   +3 more
wiley   +1 more source

The debut of benign recurrent intrahepatic cholestasis in acute hepatitis A

open access: yesТрансплантология (Москва)
Background. Benign recurrent intrahepatic cholestasis is a rare inherited disorder characterized by recurrent episodes of severe hyperbilirubinemia and pruritus that resolve spontaneously.
K. Yu. Kokina   +4 more
doaj   +1 more source

Severe drug-induced liver injury associated with prolonged use of Linezolid [PDF]

open access: yes, 2010
This study aims to describe a patient developing concomitant severe liver failure and lactic acidosis after long-term treatment with linezolid. A 55-year-old Caucasian woman developed concomitant severe liver failure and lactic acidosis after a treatment
Benoit, Dominique   +7 more
core   +1 more source

Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe

open access: yesJournal of Biophotonics, EarlyView.
The efficient discrimination of a hepatic cancer lesion and its surgical margin using autofluorescence lifetime imaging is presented. White light image of the specimen on the left and the augmented image with fluorescence lifetime data on the right.
D. Suraci   +9 more
wiley   +1 more source

Can blood eosinophil to basophil ratio, eosinophil to lymphocyte ratio and basophil to lymphocyte ratio predict the severity of intrahepatic cholestasis in pregnancy?

open access: yesCukurova Medical Journal, 2020
Purpose: The purpose of the study was to investigate the relation between inflammatory markers used for allergic diseases and intrahepatic pregnancy cholestasis (ICP).
Ayça Şolt, Derya Kanza Gül
doaj   +1 more source

Idiopathic neonatal haemochromatosis: A case report [PDF]

open access: yes, 2011
A case of neonatal hemochromatosis is reported in a premature 35-week infant who presented at birth with coffee ground vomiting and gradual appearance of grayish icter and colorless stool.
Alaee, E., Besharat, S., Zahedpasha, Y.
core   +1 more source

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy